Quote in 15 min·24/7 × 365AS9120:2025 · ISO 9001:2015 · FAA AC 00-56B
NSN 6505-01-379-5736CAGE 00NJ7
54092018981
Mesalamine Extended Release Caps
Mesalamine Extended Release Caps ASAP can help source this line with documentation review, alternate part checks, condition requirements, and account manager follow-up for urgent or planned procurement.
Shire Us Inc
Manufacturer
USA
Origin
N/A
Spec
N/A
Unit weight
Detailed description
Technical sourcing notes
N/A
Lead time
N/A
Cross references
Unrestricted
Export control
6505 Drugs and Biologicals
FSC
Why ASAP
Operations-grade aviation sourcing.
AS9120B
Quality-managed distribution
15 min
Average RFQ response, 24/7
Full trace
Documentation & certs on request
Submit RFQ
Request a quote for 54092018981
Send this part to ASAP with quantity, need-by timing, and buyer contact details. An account manager will review availability, alternates, certificates, and delivery options.
Part-specific RFQ
Submit RFQ for 54092018981
Send this part to ASAP with quantity, need-by timing, and buyer contact details. A dedicated account manager reviews availability, alternates, certificates, and delivery options.
Mesalamine Extended Release Caps54092018981
NSN6505-01-379-5736
- Manufacturer
- Shire Us Inc
- CAGE
- 00NJ7
NSN Information for Part Number 54092018981 with NSN 6505-01-379-5736, 6505013795736
Characteristics Data of NSN 6505-01-379-5736, 6505013795736
| MRC | Criteria | Characteristic |
|---|---|---|
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | MESALAMINE EXTENDED-RELEASE CAPSULES 250MG 240S BT |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| FEAT | SPECIAL FEATURES | 250 MG MESALAMINE ACTIVE INGREDIENT;THERAPEUTIC EQUIVALENT TO PENTASA BY MARION MERRILL DOW INC. |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 240 |